Biosynthesis of Antibiotics of the Virginiamycin Family, 2. Assignment of the 13C-NMR Spectra of Virginiamycin M1 and Antibiotic A2315A
Biosynthesis of Antibiotics of the Virginiamycin Family, 2. Assignment of the 13C-NMR Spectra of Virginiamycin M1 and Antibiotic A2315A
复制标题
DOI:
10.1021/np50028a008
复制
发表时间:
1983-07
影响因子:
5.1
通讯作者:
J. W. Lefevre;T. Glass;M. Kolpak;D. Kingston;Paul N. Chen
中科院分区:
文献类型:
--
作者:
J. W. Lefevre;T. Glass;M. Kolpak;D. Kingston;Paul N. Chen
As part of a biosynthetic study using 13C-labeled precursors, the 13C-nmr spectra of the antibioticsvirginiamycin and A2315A have been analyzed. Signal assign-ments were based on specific proton decoupling, chemical shift and multiplicity analysis, car-bon-carbon couplings of antibiotic biosynthesized from [l, 2-13C2] acetate and L-[U-'3C3]-serine, and comparison with model compounds.Virginiamycin(1) is a polyunsaturated cyclic peptolide antibiotic obtained from a number of different source microorganisms. It has variously been named as mikamycin A, ostreogrycin A, pristinamycin IIA, streptogramin A, PA 114 Al, and vernamycin A (1), but the name virginiamycin Mj has been accepted as the one having precedence (2). Its structure was elucidated by a combination of chemical and spectroscopic techniques (3, 4), and has been confirmed by an X-ray crystal structure(5). The antibiotic A2315A (2) differs from virginiamycin Mj in the presence of a D-alanine unit in place of the dehydroproline unit of the latter and in the oxidation level of the C-16 oxygen function (6).